- Investors & Partners
- Meet our team
- Copyright © 2023
- All rights reserved
A new drug that can identify tumors, trace metastases, and treat cancer – all in one? Belgian start-up Precirix is aiming high with its lead compound – a precision radiopharmaceutical using camelid antibodies to bind to, and irradiate, cancer cells.
Your browser is not supported. Update your browser for more security, speed and to make the most of this site.